Legend Biotech
LEGN----
Legend Biotech (LEGN)
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel c...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Legend Biotech Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
$54.23144.07%
Forecast & RatingBuy
15analysts
- Strong buy40.00%
- Buy33.33%
- Hold26.67%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · Jul 20 at 05:03 AM
Top 3 Health Care Stocks That May Rocket Higher In July
- Simplywall · Jul 17 at 08:01 AM
Legend Biotech (LEGN) Could Be 60% Undervalued Following CARVYKTI Sales Update
- Tip Ranks · Jul 15 at 07:38 AM
Genscript Highlights Strong CARVYKTI Sales via Legend Biotech, Urges Investor Caution
- PUBT · Jul 2 at 03:06 PM
Legend Biotech director Casey Patrick John disposes of 6,000 common shares for $88,800
- PUBT · Jun 22 at 03:20 PM
Legend Biotech prices 7,700,000 ADS follow-on offering at $29.35 each
- MSN · Jun 22 at 08:55 AM
As AbbVie eyes Apogee, these biotech stocks earn the highest quant ratings
